"Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial." PLoS One 12.6 (2017): e0179538
14(4):1596-1612 This story was originally published by Parade on Mar 27, 2026, where it first appeared in the Health & Wellness section
To extract relevant frame-by-frame information from the video data, we employed deep learning models that inferred bounding boxes surrounding each mouse and keypoint locations across various body parts (YOLOv8)
The results of the clinical trials that have examined the effects of selenium supplementation on thyroid autoimmunity in pregnant women have also been controversial [84, 85], and the latest ATA guidelines recommends against selenium supplementation in pregnant women [86]
Our findings suggested that Exendin-4-Fc produced a stable hypoglycemic and insulin secretion effect during the treatment period
